Table of Contents 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview 1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview 1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment by Type 1.2.1 Preface 1.2.2 Eluxadoline 1.2.3 Alosetron 1.2.4 Rifaximin 1.2.5 Loperamide 1.2.6 Diphenoxylate + Atropine 1.2.7 Dicyclomine and Hyoscyamine 1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type 1.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth by Type 1.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2014-2019) 1.3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2014-2019) 1.3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2014-2019) 2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Company 2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Company (2014-2019) 2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Company (2014-2019) 2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Company (2014-2019) 2.4 Global Top Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Sales Area, Product Types 2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation and Trends 2.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Rate 2.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Company Profiles and Sales Data 3.1 Astellas Pharmaceuticals 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification 3.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Actavis 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification 3.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Pfizer 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification 3.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 GlaxoSmithKline 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification 3.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 Salix Pharmaceuticals Ltd 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification 3.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 AstraZenenca 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification 3.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue by Regions 4.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Regions (2014-2019) 4.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Application/End Users 5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Application 5.1.1 Hospitals 5.1.2 Clinics 5.1.3 Others 5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Segment by Application 5.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application 5.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application (2014-2019) 6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast 6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue Forecast (2019-2025) 6.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Regions 6.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Type 6.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Preface Gowth Forecast 6.3.3 Eluxadoline Gowth Forecast 6.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Application 6.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2019-2025) 6.4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast in Hospitals 6.4.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast in Clinics 7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Upstream Raw Materials 7.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Status and Outlook (2014-2025) Figure Product Picture of Preface Table Major Players of Preface Figure Global Preface Sales (K Units) and Growth Rate (%)(2014-2018) Figure Product Picture of Eluxadoline Table Major Players of Eluxadoline Figure Global Eluxadoline Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Alosetron Table Major Players of Alosetron Figure Global Alosetron Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Rifaximin Table Major Players of Rifaximin Figure Global Rifaximin Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Loperamide Table Major Players of Loperamide Figure Global Loperamide Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Diphenoxylate + Atropine Table Major Players of Diphenoxylate + Atropine Figure Global Diphenoxylate + Atropine Sales (K Units) and Growth Rate (%)(2014-2019) Figure Product Picture of Dicyclomine and Hyoscyamine Table Major Players of Dicyclomine and Hyoscyamine Figure Global Dicyclomine and Hyoscyamine Sales (K Units) and Growth Rate (%)(2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Comparison by Type Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Type (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Type (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Type (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Type in 2018 Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) by Type (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share (%) by Type (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share (%) by Type (2014-2019) Figure 2018 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Type Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Company (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Company (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Company in 2018 Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) by Company (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share (%) by Company (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share (%) by Company in 2018 Table Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) by Company (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Top Players Manufacturing Base Distribution and Sales Area Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Top Players Product Category Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (%) of Top 5 Players Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share (%) of Top 10 Players Table Astellas Pharmaceuticals Basic Information List Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Global Market Share (%)(2014-2019) Table Actavis Basic Information List Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Global Market Share (%)(2014-2019) Table Pfizer Basic Information List Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Global Market Share (%)(2014-2019) Table GlaxoSmithKline Basic Information List Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Global Market Share (%)(2014-2019) Table Salix Pharmaceuticals Ltd Basic Information List Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Global Market Share (%)(2014-2019) Table AstraZenenca Basic Information List Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Global Market Share (%)(2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Regions (2014-2025) Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Regions (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Regions (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Regions Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) by Regions (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Regions (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Regions Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) (2014-2019) Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Table Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Philippines Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Philippines Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Vietnam Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Vietnam Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Table South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019) Figure North Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure North Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units)(2014-2019) Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD)(2014-2019) Figure Hospitals Examples Figure Clinics Examples Figure Others Examples Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Comparison by Application (2014-2025) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Application (2014-2019) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Application (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Application (2014-2019) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Application in 2018 Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Regions (2019-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Million USD) Forecast by Type (2019-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) Forecast by Type (2019-2025) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) Forecast by Type (2019-2025) Figure Preface Sales Growth Forecast Figure Eluxadoline Sales Growth Forecast Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Application (2019-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2019-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast in Hospitals Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast in Clinics Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Structure Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis Table Distributors List Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream Customers

Astellas Pharmaceuticals Actavis Pfizer GlaxoSmithKline Salix Pharmaceuticals Ltd AstraZenenca